Cholinesterase inhibitors block the action of cholinesterase, increasing acetylcholine availability and, subsequently, its duration of action in the brains of AD patients, which is essential for arousal, attention, learning, memory, muscle activation, etc. [9,10]. Here, BCHE is linked to Alzheimer disease.